Cost-effectiveness analysis of three surgical approaches for parathyroidectomy in secondary hyperparathyroidism patients
In the Chinese healthcare system, tPTX is considered the most cost-effective treatment for refractory hyperparathyroidism, when compared to tPTX+AT and sPTX.
Authors
- Wantao Xie (ORCID: https://orcid.org/0000-0002-8004-8818)
- Yingnan Feng (ORCID: https://orcid.org/0000-0003-1452-7279)
- Guangming Cheng (ORCID: https://orcid.org/0000-0001-5852-1341)
- Qila Sa
- Yinghui Zhou (ORCID: https://orcid.org/0000-0001-5959-2627)
- Wei Zhang (ORCID: https://orcid.org/0000-0001-6911-0900)
- Ningyuan Zhang (ORCID: https://orcid.org/0000-0002-9376-2658)
- Boyuan Nan
Institutions
- Dalian Medical University (CN)
- General Hospital of Shenyang Military Region (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-01-27
- DOI
- https://doi.org/10.3389/fendo.2024.1495818
- Citations
- 1
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.43